Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28862
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHamilton, Garry W-
dc.contributor.authorYeoh, Julian-
dc.contributor.authorDinh, Diem-
dc.contributor.authorBrennan, Angela-
dc.contributor.authorYudi, Matias B-
dc.contributor.authorFreeman, Melanie-
dc.contributor.authorHorrigan, Mark-
dc.contributor.authorMartin, Lorelle-
dc.contributor.authorReid, Christopher M-
dc.contributor.authorYip, Thomas-
dc.contributor.authorPicardo, Sandra-
dc.contributor.authorSharma, Anand-
dc.contributor.authorDuffy, Stephen J-
dc.contributor.authorFarouque, Omar-
dc.contributor.authorClark, David J-
dc.contributor.authorAjani, Andrew E-
dc.date2022-
dc.date.accessioned2022-02-22T04:30:44Z-
dc.date.available2022-02-22T04:30:44Z-
dc.date.issued2022-01-31-
dc.identifier.citationCardiovascular Revascularization Medicine : Including Molecular Interventions 2022; 41: 136-141en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28862-
dc.description.abstractPrimary percutaneous coronary intervention (PCI) for patients with ST-elevation myocardial infarction (STEMI) is recommended within 90 min of first medical contact. Those without pre-hospital notification (PN) are less likely to meet reperfusion targets and are an understudied subset of the STEMI population. An observational cohort study from a multicentre PCI registry of consecutive patients undergoing primary PCI for STEMI between 2012 and 2017. Exclusion criteria included out-of-hospital cardiac arrest, prior thrombolysis, symptom onset >12 h prior, and cardiogenic shock. 2519 patients were included: 1392 (55.3%) without PN (no-PN group) and 1127 (44.7%) with PN (PN group). Those without PN had longer median DTBT (78 min vs 51 min, p < 0.001) and STBT (206 min vs 161 min, p < 0.001), with only 55% meeting DTBT targets out-of-hours in the no-PN group. No-PN patients had lower rates of AHA/ACC type B2/C lesions, GP IIb/IIIa use, aspiration thrombectomy and had smaller stent diameter (all p ≤ 0.003), suggesting smaller areas of ischemic myocardium. There were no significant differences in 30-day MACE (no-PN 5.6% vs PN 6.5%, p = 0.36) or long-term National Death Index linked mortality (no-PN 6.2% vs PN 7.9%, p = 0.09). Lack of PN did not independently predict long-term mortality. Despite comparably excellent outcomes overall, those without PN had longer ischemic times and were less likely to meet DTBT targets, especially after hours. Ischemic times may be a better evaluation of PN networks than hard clinical outcomes, and efficient systems of care tailored to the individual health service are essential to ensure timely reperfusion of patients with STEMI.en
dc.language.isoeng-
dc.subjectDoor-to-balloon timeen
dc.subjectIschemic timeen
dc.subjectOutcomesen
dc.subjectPre-hospital notificationen
dc.subjectSTEMIen
dc.titleReperfusion times and outcomes in patients with ST-elevation myocardial infarction presenting without pre-hospital notification.en
dc.typeJournal Articleen
dc.identifier.journaltitleCardiovascular revascularization medicine : including molecular interventionsen
dc.identifier.affiliationDepartment of Cardiology, Box Hill Hospital, Melbourne, Australia..en
dc.identifier.affiliationDepartment of Cardiology, Ballarat Base Hospital, Ballarat, Australia..en
dc.identifier.affiliationCentre of Cardiovascular Research and Education in Therapeutics (CCRET), Monash University, Melbourne, Australia..en
dc.identifier.affiliationDepartment of Cardiology, Royal Melbourne Hospital, Melbourne, Australia..en
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, Australia..en
dc.identifier.affiliationDepartment of Cardiology, Alfred Hospital, Melbourne, Australia..en
dc.identifier.affiliationSchool of Public Health, Curtin University, Perth, Western Australia, Australia..en
dc.identifier.affiliationCardiologyen
dc.identifier.affiliationDepartment of Cardiology, University Hospital, Geelong, Australia..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35165049/en
dc.identifier.doi10.1016/j.carrev.2022.01.024en
dc.type.contentTexten
dc.identifier.orcid0000-0002-8900-7529en
dc.identifier.orcid0000-0003-4957-186Xen
dc.identifier.orcid0000-0002-3706-4150en
dc.identifier.orcid0000-0002-5457-0856en
dc.identifier.orcid0000-0003-2821-1451en
dc.identifier.pubmedid35165049-
local.name.researcherClark, David J
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptCardiology-
crisitem.author.deptCardiology-
crisitem.author.deptCardiology-
crisitem.author.deptCardiology-
crisitem.author.deptCardiology-
crisitem.author.deptCardiology-
crisitem.author.deptUniversity of Melbourne Clinical School-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

44
checked on Oct 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.